EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bruton’s Tyrosine Kinase Inhibitors: Recent Updates

Amneh Fares, Carlos Carracedo Uribe, Diana Martinez, Tauseef Rehman iD, Carlos Silva Rondon, Jose Sandoval-Sus

International Journal of Molecular Sciences · 12.02.2024 · 25 (4) · 2208

DOI: 10.3390/ijms25042208 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 12.02.2024. Verfasst von Amneh Fares und 5 weiteren Autor:innen. Beteiligte Einrichtung: Memorial Healthcare System, Pembroke Pines, FL 33021, USA. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Neoplasms. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bruton’s tyrosine kinase (BTK) inhibitors have revolutionized the landscape for the treatment of hematological malignancies, solid tumors, and, recently, autoimmune disorders. The BTK receptor is expressed in several hematopoietic cells such as macrophages, neutrophils, mast cells, and osteoclasts. Similarly, the BTK receptor is involved in signaling pathways such as chemokine receptor signaling, Toll-like receptor signaling, and Fc receptor signaling. Due to their unique mechanism, these agents provide a diverse utility in a variety of disease states not limited to the field of malignant hematology and are generally well-tolerated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHematologic NeoplasmsHumansAgammaglobulinaemia Tyrosine KinaseTyrosine Kinase InhibitorsSignal TransductionProtein Kinase Inhibitors

Stichwörter der Autor:innen

Bruton’s kinase inhibitorsacalabrutinibautoimmune disordershematologic malignanciesibrutinibpirtobrutinibzanubrutinib

Substanzen

Agammaglobulinaemia Tyrosine KinaseTyrosine Kinase InhibitorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Memorial Healthcare System, Pembroke Pines, FL 33021, USA.
  • Moffitt Malignant Hematology at Memorial Healthcare System, Pembroke Pines, FL 33021, USA.

ORCID-Profile: Tauseef Rehman

Zitieren

APA

Fares, A., Carracedo Uribe, C., Martinez, D., Rehman, T., Silva Rondon, C., & Sandoval-Sus, J. (2024). Bruton’s Tyrosine Kinase Inhibitors: Recent Updates. International Journal of Molecular Sciences, 25(4), 2208. https://doi.org/10.3390/ijms25042208

Vancouver

Fares A, Carracedo Uribe C, Martinez D, Rehman T, Silva Rondon C, Sandoval-Sus J. Bruton’s Tyrosine Kinase Inhibitors: Recent Updates. International Journal of Molecular Sciences. 2024;25(4):2208. doi:10.3390/ijms25042208

BibTeX
@article{Fares2024,
  author = {Fares, Amneh and Carracedo Uribe, Carlos and Martinez, Diana and Rehman, Tauseef and Silva Rondon, Carlos and Sandoval-Sus, Jose},
  title = {Bruton’s Tyrosine Kinase Inhibitors: Recent Updates},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {4},
  pages = {2208},
  doi = {10.3390/ijms25042208}
}
Kostenlos starten →